Biophytis announces positive final results of the phase 2-3

Biophytis / Key word(s): Miscellaneous Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO1...

Related Keywords

France , Portugal , Brazil , United States , Paris , France General , Massachusetts , Washington , Belgium , China , Estoril , Lisboa , Veillet , Rhôalpes , Cambridge , Cambridgeshire , United Kingdom , America , American , Kaplan Meier , Agathe Boggio , Antoine Denry , Exchange Commission , Company Or Biophytis , Early Access Program , European Respiratory Society Lung Science , American Thoracic Society , Early Access Programs , Marketing Authorisation , Euronext Growth Paris , Top Line , Emergency Use Authorization , Intensice Care Units , Intent To Treat , Per Protocol , Latin America , Duchenne Muscular Dystrophy , Euronext Growth , American Depositary Shares , Nasdaq Capital Market , Year Financial Report ,